Shares of Telix Pharmaceuticals Limited (TLX) are falling about 10 percent on Monday morning after the company announced a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE to strengthen Telix's leadership as a vertically integrated radiopharmaceutical company.The company's stock is currently trading at $11.28, down 10.38 percent, over the previous close of $12.59 on the Nasdaq. It has traded between $6.28 and $13.11 in the past one year. Subscribe to continue reading the articl ...